The PRDM13 gene helps control how certain cells develop, especially in the retina, the light sensing tissue at the back of the eye. This gene plays an important role in shaping the macula, which supports sharp central vision for tasks like reading and recognizing faces. Rare variants that change when or how strongly this gene is active can lead to an inherited eye condition called North Carolina macular dystrophy, causing central vision changes that range from mild to more noticeable.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly help regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PRDM13Gene function
What if the gene works
The PRDM13 gene helps control when other genes turn on during early development, especially in the retina and nervous system. This supports normal formation of some eye and nerve cells.
Risk
What if the gene does not work
Changes in or near the PRDM13 gene are linked to inherited retinal conditions, especially North Carolina macular dystrophy. Vision changes can range from mild blind spots to marked central vision loss, often present from birth, depending on the variant.
Treatment
What does that mean for your treatment
A pathogenic variant in the PRDM13 gene currently does not have an established gene-specific treatment or drug choice in clinical guidelines. Care is based on a person’s eye findings and vision needs, while PRDM13 remains an active research focus in inherited retinal conditions.
Gene function
What if the gene works
During early development, the PRDM13 gene helps guide how certain nerve cells take shape and connect. A key part of PRDM13 gene function in the developing eye and spinal cord is helping early cells choose the right identity. This steady guidance supports organized nerve circuits as the body forms.
The PRDM13 gene helps manage when other genes are turned on or kept quiet during development. This gives young cells timely instructions as they mature into specialized nerve cells.
It helps early nerve cells choose the right role, especially cells that fine tune or quiet signaling. That choice is important for balanced communication in growing nerve circuits.
In the developing retina and spinal cord, PRDM13 helps place certain nerve cells in the right areas. Orderly placement supports the formation of clear visual and sensory pathways.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help account for normal human diversity, such as variations in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most disease linked changes around the PRDM13 gene do not damage the protein itself. In understanding how PRDM13 gene variants affect retinal development, the key point is that many lie in nearby DNA control regions and can raise PRDM13 activity at the wrong time or in the wrong cells as the macula forms. Larger duplications or stronger regulatory variants may shift gene activity more and are often linked to earlier, more marked macular changes, while milder variants can have subtler effects.
How variants are linked to conditions
Variants in or near the PRDM13 gene are linked to North Carolina macular dystrophy, a rare inherited eye condition that affects the center of the retina. These PRDM13 gene variants linked to North Carolina macular dystrophy can confirm the diagnosis in families with the condition. Severity varies widely, from little day to day impact to blind spots or reduced central vision.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead represent natural human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PRDM13, risk is mainly tied to whether a disease-causing change is present in the family, rather than to lifestyle or everyday exposures. There is not broadly confirmed evidence that specific habits or environmental factors increase or lower the chance of developing a PRDM13-related eye condition.
Inheritance of PRDM13 variants
PRDM13-related eye conditions that are clearly established in human genetics are inherited in an autosomal dominant pattern. That means a parent with a disease-causing PRDM13 variant can pass it to a son or daughter, and each child has a 1 in 2, or 50%, chance of inheriting it. In families asking how PRDM13 variants are inherited, the key point is that one altered copy of the PRDM13 gene is enough to be passed on with this pattern. Mothers and fathers can both pass the variant to children of any sex.
What does my PRDM13 result mean for my family?
For PRDM13, a disease-causing result is most often linked to an inherited eye condition that can run in families in a dominant pattern, so close relatives such as a parent, brother, sister, or child may also carry the same change. That means family members may have similar retinal findings, even when vision problems are mild or vary from one person to another. In some families, relatives may wish to discuss eye exams or genetic testing with their care team.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to the PRDM13 gene, doctors use genetic testing for PRDM13 variants on a blood or saliva sample. The lab reads the DNA code and may also check for extra or missing pieces of DNA near the PRDM13 gene, because some clinically important variants affect nearby control regions rather than the gene itself.
When should I consider getting a genetic test?
Consider PRDM13 testing if you or close relatives have a rare inherited eye condition affecting the macula, the center of the retina, especially when central vision changes began at birth or in childhood. Testing can help confirm whether this condition is running in the family.
A genetic result is only one part of your health story
What you can learn from a genetic result varies based on the condition involved and the type of variant identified. Over time, body function is also shaped by factors such as lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment at the same dose, yet one may get the intended benefit while the other may notice less effect or more side effects. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug, which can influence how strongly it works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that examines how genetic differences affect the way people respond to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the PRDM13 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any questions about symptoms, treatment, or side effects are best discussed with your doctor.
History
PRDM13 entered medical genetics more recently than many well known genes, through research on inherited eye conditions and early development. In recent decades, awareness of this gene’s role has grown as scientists mapped a region on chromosome 6 linked to North Carolina macular dystrophy, a rare condition that can run in families. Building on this early work, researchers identified changes near the PRDM13 gene as a key explanation for many affected families. This was an important step because it showed that changes outside the coding part of a gene could still strongly influence health. As genetic testing improved, PRDM13 became part of a broader shift toward recognizing noncoding variants in inherited disease. These historical steps shaped today’s understanding of PRDM13 in clinical genetics.